Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry
Özet
Objective: In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. Methods: The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). Results: After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. Conclusion: The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment. © 2021 Turkish Society of Cardiology. All rights reserved.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Erol, Mustafa Kemal | |
| dc.contributor.author | Kayikçioglu, Meral | |
| dc.contributor.author | Yavuzgil, Oguz | |
| dc.contributor.author | Kiliçkap, Mustafa | |
| dc.contributor.author | Güler, Arda | |
| dc.contributor.author | Öztürk, Önder | |
| dc.contributor.author | Tuncay, Burcu | |
| dc.contributor.author | Inci, Sinan | |
| dc.contributor.author | Balaban, Ismail | |
| dc.contributor.author | Tatar, Fatih Pasa | |
| dc.contributor.author | Çirakoglu, Ömer Faruk | |
| dc.contributor.author | Gazi, Emine | |
| dc.contributor.author | Bakirci, Eftal Murat | |
| dc.contributor.author | Yayla, Cągri | |
| dc.contributor.author | Astarcioglu, Mehmet Ali | |
| dc.contributor.author | Karaduman, Bilge Duran | |
| dc.contributor.author | Aksu, Ekrem | |
| dc.contributor.author | Alsancak, Yakup | |
| dc.contributor.author | Emlek, Nadir | |
| dc.contributor.author | Tigen, Mustafa Kürsat | |
| dc.contributor.author | Cąglar, Nihan Turhan | |
| dc.contributor.author | Düz, Ramazan | |
| dc.contributor.author | Inanir, Mehmet | |
| dc.contributor.author | Özdogan, Öner | |
| dc.date.accessioned | 2026-10-18T20:28:11.924401489Z | |
| dc.date.available | 2026-10-18T20:28:11.924401489Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | Objective: In this study, we aimed to analyze the TURKMI registry to identify the factors associated with delays from symptom onset to treatment that would be the focus of improvement efforts in patients with acute myocardial infarction (AMI) in Turkey. Methods: The TURKMI study is a nation-wide registry that was conducted in 50 centers capable of 24/7 primary percutaneous coronary intervention (PCI). All consecutive patients (n=1930) with AMI admitted to coronary care units within 48 hours of symptom onset were prospectively enrolled during a predefined 2-week period between November 1, 2018, and November 16, 2018. All the patients were examined in detail with regard to the time elapsed at each step from symptom onset to initiation of treatment, including door-to-balloon time (D2B) and total ischemic time (TIT). Results: After excluding patients who suffered an AMI within the hospital (2.6%), the analysis was conducted for 1879 patients. Most of the patients (49.5%) arrived by self-transport, 11.8% by emergency medical service (EMS) ambulance, and 38.6% were transferred from another EMS without PCI capability. The median time delay from symptom-onset to EMS call was 52.5 (15-180) min and from EMS call to EMS arrival 15 (10-20) min. In ST-segment elevation myocardial infarction (STEMI), the median D2B time was 36.5 (25-63) min, and median TIT was 195 (115-330) min. TIT was significantly prolonged from 151 (90-285) min to 250 (165-372) min in patients transferred from non-PCI centers. The major significant factors associated with time delay were patient-related delay and the mode of hospital arrival, both in STEMI and non-STEMI. Conclusion: The baseline evaluation of the TURKMI study revealed that an important proportion of patients presenting with AMI within 48 hours of symptom onset reach the PCI treatment center later than the time proposed in the guidelines, and the use of EMS for admission to hospital is extremely low in Turkey. Patient-related factors and the mode of hospital admission were the major factors associated with the time delay to treatment. © 2021 Turkish Society of Cardiology. All rights reserved. | |
| dc.description.sponsorship | Acknowledgments: Statistical analyses were conducted by Omega CRO, Ankara, Turkey. The electronic case report form and the data capture program (OpenClinica LLC and collaborators, Waltham, MA, USA) hosted were by Omega CRO, Ankara, Turkey. TURKMI registries are investigator-initiated trials and sponsored by the Turkish Society of Cardiology, which received major, unrestricted funding from AstraZeneca for this project. The funder had no role in study design, data collection, data analysis, data interpretation, or writing of the report. | |
| dc.identifier.doi | 10.5152/anatoljcardiol.2021.39797 | |
| dc.identifier.eissn | 2149-2271 | |
| dc.identifier.endpage | 303 | |
| dc.identifier.issn | 2149-2263 | |
| dc.identifier.issue | 5 | |
| dc.identifier.pmcid | PMC8114620 | |
| dc.identifier.pmid | 33960304 | |
| dc.identifier.scopus | 2-s2.0-85105521990 | |
| dc.identifier.startpage | 294 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/13356 | |
| dc.identifier.volume | 25 | |
| dc.language.iso | en | |
| dc.publisher | Turkish Society of Cardiology | |
| dc.relation.ispartof | Anatolian Journal of Cardiology | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Ambulance | |
| dc.subject | Door to balloon time | |
| dc.subject | Myocardial infarction | |
| dc.subject | Total ischemic time | |
| dc.subject | Treatment delay | |
| dc.subject | Emergency Medical Services | |
| dc.subject | Humans | |
| dc.subject | Percutaneous Coronary Intervention | |
| dc.subject | Registries | |
| dc.subject | ST Elevation Myocardial Infarction | |
| dc.subject | Time Factors | |
| dc.subject | acute heart infarction | |
| dc.subject | adult | |
| dc.subject | ambulance transportation | |
| dc.subject | Article | |
| dc.subject | cardiovascular symptom | |
| dc.subject | coronary angiography | |
| dc.subject | coronary care unit | |
| dc.subject | door-to-balloon time | |
| dc.subject | emergency health service | |
| dc.subject | emergency response time | |
| dc.subject | female | |
| dc.subject | fibrinolytic therapy | |
| dc.subject | health care quality | |
| dc.subject | hospital admission | |
| dc.subject | hospitalization | |
| dc.subject | human | |
| dc.subject | ischemia time | |
| dc.subject | major clinical study | |
| dc.subject | male | |
| dc.title | Time delays in each step from symptom onset to treatment in acute myocardial infarction: Results from a nation-wide TURKMI registry | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 16 | |
| rdl.citation.trdizin | 2 | |
| rdl.department | NECMETTİN ERBAKAN ÜNİVERSİTESİ | |
| rdl.department | KAHRAMANMARAŞ SÜTÇÜ İMAM ÜNİVERSİTESİ | |
| rdl.department | BOLU ABANT İZZET BAYSAL ÜNİVERSİTESİ | |
| rdl.department | AKSARAY ÜNİVERSİTESİ | |
| rdl.department | SAĞLIK BİLİMLERİ ÜNİVERSİTESİ | |
| rdl.department | EGE ÜNİVERSİTESİ | |
| rdl.department | ERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ | |
| rdl.department | KÜTAHYA DUMLUPINAR ÜNİVERSİTESİ | |
| rdl.department | ANKARA YILDIRIM BEYAZIT ÜNİVERSİTESİ | |
| rdl.department | ÇANAKKALE ONSEKİZ MART ÜNİVERSİTESİ | |
| rdl.department | T.C. SAĞLIK BAKANLIĞI | |
| rdl.department | ANKARA ÜNİVERSİTESİ | |
| rdl.department | ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ | |
| rdl.department | RECEP TAYYİP ERDOĞAN ÜNİVERSİTESİ | |
| rdl.department | MARMARA ÜNİVERSİTESİ | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | TRDIZIN | |
| rdl.source.index | PUBMED |
